FDA approves Mercks Keytruda (pembrolizumab) for the adjuvant treatment of patients with melanoma with involvement of lymph nodes following complete r...
An Arizona federal judge denies a Goldwater Institute attorneys request to force FDA to tell how it decides whether to allow dying patients access to ...
FDA accepts a Clearside Biomedical 505(b)(2) NDA for Xipere (triamcinolone acetonide ophthalmic suspension) for suprachoroidal injection for treating ...
FDA clears a Royal Philips 510(k) for the DigitalDiagnost C90, its newest digital radiography system.
Federal Register notice: FDA issues a final rule to establish criteria for and identify an initial list of bulk drug substances that can be used to co...
FDA and Arca Biopharma reach agreement on a special protocol assessment for a Phase 3 trial of the companys Gencaro to treat atrial fibrillation in ce...
FTC says it has reached a global settlement with Teva to ban two types of reverse-payment patent settlements.
FDA Oncology Center of Excellence director Richard Pazdur reviews several drug trials using the pathological complete response rate regulatory endpoin...